Merck Awarded its First CRISPR Patent by Australian Patent OfficeLabmate OnlineThe patent is the first that Merck has received for CRISPR technology. The patent covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells … Continue reading
Merck Awarded its First CRISPR Patent by Australian Patent OfficeLabmate OnlineThe patent is the first that Merck has received for CRISPR technology. The patent covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells … Continue reading
Technology Networks |
Find youth in Zen Institute’s stem cell therapy
Malaya “The secret to the efficacy of stem cell therapy is that unlike previous anti-aging techniques that focus on preserving and optimizing cellular health, or on simply “masking” the visible effects of aging, Stem Cell Therapy significantly restores your … Breakthrough made in stem cells scienceIndependent Online Skin Cells Directly Converted into Motor NeuronsTechnology Networks |
Daily News & Analysis |
Find youth in Zen Institute’s stem cell therapy
Malaya “The secret to the efficacy of stem cell therapy is that unlike previous anti-aging techniques that focus on preserving and optimizing cellular health, or on simply “masking” the visible effects of aging, Stem Cell Therapy significantly restores your … Breakthrough made in stem cells scienceIndependent Online Human skin cells turned directly into motor neuronsDaily News & Analysis |
OPB News |
‘The Four Top’: CRISPR Over GMOs? | Endangered Foods | Banking …
OPB News Bananas are among the many endangered plant species millions of humans consume on a daily basis. Mike Dorner/Unsplash. Have you heard about the … |
|
Warum der Genome-Editing-Pionier Editas im August um 18,8 % steigen konnte
Boerse-express.com Das Unternehmen gab an, man hätte inzwischen auch ein Patent für CRISPR–Cpf1 eingereicht, einen Genome-Editing-Ansatz, bei dem die Zahl der reparaturfähigen Ansatzpunkte verändert, besser hergestellt und damit die Gen-Reparatur im Vergleich zu … |
|
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and …
Markets Insider PLYMOUTH MEETING, Pa., Sept. 11, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis … |
|
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In …
Nasdaq PLYMOUTH MEETING, Pa., Sept. 11, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that an interim data analysis showed that its INO-5150 cancer immunotherapy product generated antigen-specific CD8+ killer … |